Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Differential Effect of Rituximab on Relapse-Free Survival in De Novo and Relapsed Immune Thrombotic Thrombocytopenic Purpura in African-American and Caucasian Populations

Blood (2019) 134 (Supplement_1): 90.

https://doi.org/10.1182/blood-2019-129383

Published: 2019

Journal Articles

African American Race Is Associated with Decreased Relapse-Free Survival in Immune Thrombotic Thrombocytopenic Purpura

Blood (2019) 134 (Supplement_1): 1066.

https://doi.org/10.1182/blood-2019-131064

Published: 2019

Journal Articles

Efficacy of Adjuvant Low Dose Rituximab and Plasma Exchange for Acquired TTP with Severe ADAMTS13 Deficiency — Results of the ART Study

J. Evan Sadler, MD PhD, Joshua Muia, PhD, Leili Dolatshahi, MD, Lisa A. Westfield, MA, Patricia Nieters, RN, BSN, Anita Rodrigues, BA, Ana G. Antun, MD, Ara Metjian, MD, Jeffrey I. Zwicker, MD

Blood (2018) 132 (Supplement 1): 374.

https://doi.org/10.1182/blood-2018-99-113677

Published: 2018

Journal Articles

A Descriptive Analysis of the Demographics and Presenting Symptoms of Patients in the U.S. Thrombotic Microangiopathy (USTMA) TTP Registry

Elizabeth Davis, Ana G. Antun, MD, Lisa Baumann Kreuziger, MD MS, J. Evan Sadler, MD PhD, Spero R Cataland, MD, Meera Sridharan, MD, Todd Clover, MD, Andrew Johnson, MD, Keith McCrae, MD, Shruti Chaturvedi, MBBS,MS, Ronald S. Go, MD, Ming Yeong Lim, MBBChir, Marshall A. Mazepa, MD

Blood (2017) 130 (Supplement 1): 1049.

https://doi.org/10.1182/blood.V130.Suppl_1.1049.1049

Published: 2017

Journal Articles

Factors Associated with Mortality in Immune-Mediated Thrombotic Thrombocytopenic Purpura: Results from the United States Thrombotic Microangiopathy TTP Registry

Todd Clover, MD MS, Ronald S. Go, MD, Ana G. Antun, MD, Spero R Cataland, MD, Shruti Chaturvedi, MBBS,MS, Elizabeth Davis, Andrew Johnson, MD, Ming Yeong Lim, MBBChir, Meera Sridharan, MD, Keith McCrae, MD, J. Evan Sadler, MD PhD, Marshall A. Mazepa, MD, Lisa Baumann-Kreuziger, MS MD

Blood (2017) 130 (Supplement 1): 3624.

https://doi.org/10.1182/blood.V130.Suppl_1.3624.3624

Published: 2017

Journal Articles

The Impact of Detectable ADAMTS13 Inhibitor on the Clinical Presentation and Outcome of Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP): Analysis Using the United States Thrombotic Microangiopathy (USTMA) Clinical Registry

Meera Sridharan, MD, Ana G Antun, MD, Lisa Baumann Kreuziger, Assistant Professor. MD MS, Spero R Cataland, MD, Shruti Chaturvedi, MBBS,MS, Todd Clover, MD, Elizabeth Davis, Andrew Johnson, MD, Keith McCrae, MD, Ming Yeong Lim, MBBChir, J. Evan Sadler, MD PhD, Marshall A. Mazepa, MD, Ronald S Go, MD

Blood (2017) 130 (Supplement 1): 3620.

https://doi.org/10.1182/blood.V130.Suppl_1.3620.3620

Published: 2017

Journal Articles

Survival of Patients Diagnosed with Primary Refractory and Relapsed Acute Myeloid Leukemia from 2008-2012: A Single Institution Experience

Simon B. Zeichner, D.O., Shannon Gleason, M.L.S., Ana G. Antun, MD, Amelia Langston, MD, Leonard T Heffner, Jr., MD, Vamsi K Kota, MD, Manila Gaddh, MD, Martha Arellano, MD

Blood (2015) 126 (23): 4955.

https://doi.org/10.1182/blood.V126.23.4955.4955

Published: 2015

Journal Articles

Numeracy in Patients with Hemophilia

Duc Q. Tran, MD MSc, Vaughn Barry, PhD MPH, Ana G. Antun, MD, Maria Ribeiro, MD, Sidney F. Stein, MD, Christine L Kempton, MD MSc

Blood (2015) 126 (23): 40.

https://doi.org/10.1182/blood.V126.23.40.40

Published: 2015

Journal Articles

The Impact of Health Literacy on Adherence to Factor Replacement in the Hemophilia Population

Duc Q. Tran, MD, Vaughn Barry, PhD MPH, Ana G. Antun, MD, Maria J.A. Ribeiro, MD, Sidney F. Stein, MD, Christine L. Kempton, MD

Blood (2014) 124 (21): 2173.

https://doi.org/10.1182/blood.V124.21.2173.2173

Published: 2014

Journal Articles

Distress in Patients with Bleeding Disorders

Vaughn Barry, PhD MPH, Duc Q. Tran, MD, Mary Ellen Lynch, PhD, Hilary G Cohen, LCSW, CTS, DVC (III), Cedric Truss, MSHI, Kesley Tyson, MS, CCRP, Ana G. Antun, MD, Anthony DeBalsi, NP, Shanna Mattis, MPH, Maria J.A. Ribeiro, MD, Sidney F. Stein, MD, Christine L. Kempton, MD

Blood (2014) 124 (21): 201.

https://doi.org/10.1182/blood.V124.21.201.201

Published: 2014

Journal Articles

Natural History Of Inhibitor Recurrence Following Successful Immune Tolerance Induction

Ana G. Antun, MD, Paul Monahan, MD, Marilyn J. Manco-Johnson, MD, Michael Callaghan, MD, Guy Young, MD, Christine Knoll, MD, Shannon Carpenter, MD, MS, Joanna A. Davis, MD, Michael F. Guerrera, MD, Rebecca Kruse-Jarres, MD, MPH, Margaret V. Ragni, MD, MPH, Char Witmer, MD, MSCE, Courtney E. McCracken, PhD, Maralee Kanin, Christine L. Kempton, MD, MSc

Blood (2013) 122 (21): 1106.

https://doi.org/10.1182/blood.V122.21.1106.1106

Published: 2013

Journal Articles

Cooperative Interaction Between Classical and Non-Classical Factor VIII C2 Domain Antibody Epitopes.

Ana G Antun, MD, Shannon L Meeks, MD, John F Healey, BS, Ernest T Parker, BS, Pete Lollar, MD

Blood (2009) 114 (22): 219.

https://doi.org/10.1182/blood.V114.22.219.219

Published: 2009

NARROW

Differential Effect of Rituximab on Relapse-Free Survival in De Novo and Relapsed Immune Thrombotic Thrombocytopenic Purpura in African-American and Caucasian Populations

African American Race Is Associated with Decreased Relapse-Free Survival in Immune Thrombotic Thrombocytopenic Purpura

Efficacy of Adjuvant Low Dose Rituximab and Plasma Exchange for Acquired TTP with Severe ADAMTS13 Deficiency — Results of the ART Study

A Descriptive Analysis of the Demographics and Presenting Symptoms of Patients in the U.S. Thrombotic Microangiopathy (USTMA) TTP Registry

Factors Associated with Mortality in Immune-Mediated Thrombotic Thrombocytopenic Purpura: Results from the United States Thrombotic Microangiopathy TTP Registry

The Impact of Detectable ADAMTS13 Inhibitor on the Clinical Presentation and Outcome of Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP): Analysis Using the United States Thrombotic Microangiopathy (USTMA) Clinical Registry

Survival of Patients Diagnosed with Primary Refractory and Relapsed Acute Myeloid Leukemia from 2008-2012: A Single Institution Experience

Numeracy in Patients with Hemophilia

The Impact of Health Literacy on Adherence to Factor Replacement in the Hemophilia Population

Distress in Patients with Bleeding Disorders

Natural History Of Inhibitor Recurrence Following Successful Immune Tolerance Induction

Cooperative Interaction Between Classical and Non-Classical Factor VIII C2 Domain Antibody Epitopes.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only